BECKIE TURNER: Open Payments
NPI 1881835122 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 15 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $0 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| SI-BONE, INC. | 1 | $137 |
| Dexcom, Inc. | 2 | $71 |
| Madrigal Pharmaceuticals | 1 | $45 |
| PFIZER INC. | 2 | $42 |
| Novo Nordisk Inc | 2 | $38 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| ABBVIE INC. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $20 |
| ALK-Abello, Inc | 1 | $15 |
Products named: Dexcom G6 Transmitter, REZDIFFRA, PREVNAR 20, FANAPT, CREON, XIFAXAN, Ozempic, MOUNJARO.
Industry payments across CA — which companies pay providers there.
